BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20835834)

  • 41. Cloning the genes and DNA binding properties of High Mobility Group B1 (HMGB1) proteins from the human blood flukes Schistosoma mansoni and Schistosoma japonicum.
    de Oliveira FM; de Abreu da Silva IC; Rumjanek FD; Dias-Neto E; Guimarães PE; Verjovski-Almeida S; Stros M; Fantappié MR
    Gene; 2006 Aug; 377():33-45. PubMed ID: 16644144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors.
    Lotfi R; Lee JJ; Lotze MT
    J Immunother; 2007 Jan; 30(1):16-28. PubMed ID: 17198080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The extracellular role of high mobility group box-1 protein in regulation of immune response].
    Tang LM; Lu ZQ; Yao YM
    Sheng Li Ke Xue Jin Zhan; 2011 Jun; 42(3):188-94. PubMed ID: 21932516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1.
    Hoppe G; Talcott KE; Bhattacharya SK; Crabb JW; Sears JE
    Exp Cell Res; 2006 Nov; 312(18):3526-38. PubMed ID: 16962095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leukocyte HMGB1 is required for vessel remodeling in regenerating muscles.
    Campana L; Santarella F; Esposito A; Maugeri N; Rigamonti E; Monno A; Canu T; Del Maschio A; Bianchi ME; Manfredi AA; Rovere-Querini P
    J Immunol; 2014 Jun; 192(11):5257-64. PubMed ID: 24752445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interplay between human high mobility group protein 1 and replication protein A on psoralen-cross-linked DNA.
    Reddy MC; Christensen J; Vasquez KM
    Biochemistry; 2005 Mar; 44(11):4188-95. PubMed ID: 15766246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
    Jung Y; Lippard SJ
    Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The gesture life of high mobility group box 1.
    Friedman SG; Czura CJ; Tracey KJ
    Curr Opin Clin Nutr Metab Care; 2003 May; 6(3):283-7. PubMed ID: 12690260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HMGB1 release in co-cultures of porcine endothelial and human T cells.
    Kawahara K; Setoyama K; Kikuchi K; Biswas KK; Kamimura R; Iwata M; Ito T; Morimoto Y; Hashiguchi T; Takao S; Maruyama I
    Xenotransplantation; 2007 Nov; 14(6):636-41. PubMed ID: 17991152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mycobacterial infection induces the secretion of high-mobility group box 1 protein.
    Grover A; Taylor J; Troudt J; Keyser A; Sommersted K; Schenkel A; Izzo AA
    Cell Microbiol; 2008 Jun; 10(6):1390-404. PubMed ID: 18331466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal models.
    Schaper F; Heeringa P; Bijl M; Westra J
    Curr Opin Rheumatol; 2013 Mar; 25(2):254-9. PubMed ID: 23249831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18β-glycyrrhetic acid inhibits immune activation triggered by HMGB1, a pro-inflammatory protein found in the tear fluid during conjunctivitis and blepharitis.
    Cavone L; Muzzi M; Mencucci R; Sparatore B; Pedrazzi M; Moroni F; Chiarugi A
    Ocul Immunol Inflamm; 2011 Jun; 19(3):180-5. PubMed ID: 21426233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.
    Yang H; Wang H; Chavan SS; Andersson U
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S6-S12. PubMed ID: 26605648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HMGB1: guiding immunity from within.
    Dumitriu IE; Baruah P; Manfredi AA; Bianchi ME; Rovere-Querini P
    Trends Immunol; 2005 Jul; 26(7):381-7. PubMed ID: 15978523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HMGB1: An immmune odyssey.
    Dumitriu IE; Baruah P; Manfredi AA; Bianchi ME; Rovere-Querini P
    Discov Med; 2005 Aug; 5(28):388-92. PubMed ID: 20704878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of high mobility group box-1 protein on immune cells and its regulatory mechanism.
    Luan YY; Yao FH; Zhang QH; Zhu XM; Dong N; Yao YM
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Nov; 28(6):548-54. PubMed ID: 23581184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Janus tale of two active high mobility group box 1 (HMGB1) redox states.
    Tang D; Billiar TR; Lotze MT
    Mol Med; 2012 Dec; 18(1):1360-2. PubMed ID: 23073660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.
    Lu B; Wang C; Wang M; Li W; Chen F; Tracey KJ; Wang H
    Expert Rev Clin Immunol; 2014 Jun; 10(6):713-27. PubMed ID: 24746113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.
    Yuan S; Liu Z; Xu Z; Liu J; Zhang J
    J Hematol Oncol; 2020 Jul; 13(1):91. PubMed ID: 32660524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions.
    Ferrara M; Chialli G; Ferreira LM; Ruggieri E; Careccia G; Preti A; Piccirillo R; Bianchi ME; Sitia G; Venereau E
    Front Immunol; 2020; 11():1122. PubMed ID: 32670275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.